SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-22-013843
Filing Date
2022-04-07
Accepted
2022-04-07 16:10:34
Documents
7
Period of Report
2022-06-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A rgnx-def14a_20220603.htm DEF 14A 1808386
2 GRAPHIC gxuwdf3dlju5000004.jpg GRAPHIC 37725
3 GRAPHIC gxuwdf3dlju5000005.jpg GRAPHIC 58071
4 GRAPHIC gxuwdf3dlju5000001.jpg GRAPHIC 3794
5 GRAPHIC gxuwdf3dlju5000003.jpg GRAPHIC 4870
6 GRAPHIC gxuwdf3dlju5000002.jpg GRAPHIC 1714
7 GRAPHIC gxuwdf3dlju5000006.jpg GRAPHIC 60588
  Complete submission text file 0001564590-22-013843.txt   2040075
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37553 | Film No.: 22813967
SIC: 2836 Biological Products, (No Diagnostic Substances)